Coherus Oncology, Inc. (CHRS)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q2-2026 | 8-K (2026-08-05) · 99.1 | ||
| 10-Q | Q1-2026 | 8-K (2026-05-11) · 99.1 | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-09) · 99.1 | 8-K (2026-01-13) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-06) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-07) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-12) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-03-10) · 99.1 | 8-K (2025-01-13) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-06) · 99.1 | ||
| 10-Q | Q2-2024 | 8-K (2024-08-08) · 99.1 | ||
| 10-Q | Q1-2024 | 8-K (2024-05-09) · 99.1 | ||
| 10-K | FY-2023 | 8-K (2024-03-13) · 99.1 | 8-K (2024-01-10) · 99.1 | ||
| 10-Q | Q3-2023 | 8-K (2023-11-06) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Condensed Consolidated Statements of Operations and Comprehensive Income (loss) | — |
|
| Condensed Consolidated Statements of Operations and Comprehensive Loss | — |
|
| Consolidated Statements of Operations | ||
| Consolidated Statements of Comprehensive Income | — |
|
| Consolidated Statements of Comprehensive Income (loss) | ||
| Consolidated Statements of Comprehensive Loss | ||
| Consolidated Statements of Stockholders' Equity (deficit) | ||
| Consolidated Statements of Cash Flows | ||
| Consolidated Statements of Stockholders' Deficit | ||
| Notes | ||
| Acquisition and Disposition | ||
| Balance Sheet Components | ||
| Collaborations and Other Arrangements | ||
| Commitments and Contingencies | ||
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Debt Obligations | ||
| Derivatives | — |
|
| Discontinued Operations | ||
| Fair Value Measurements | ||
| Financial Liabilities | ||
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Inventory | ||
| Inventory and Prepaid Manufacturing | ||
| Leases | — |
|
| Net Income (loss) Per Share | ||
| Net Loss Per Share | ||
| Organization and Significant Accounting Policies | — |
|
| Organization and Summary of Significant Accounting Policies | ||
| Pay Vs Performance Disclosure | ||
| Related Party Transactions | — |
|
| Restructuring Charges | ||
| Revenue | ||
| Stock-based Compensation | ||
| Stock-based Compensation and Employee Benefits | — |
|
| Stockholders' Deficit | ||
| Stockholders' Equity | — |
|
| Stockholders' Equity (deficit) | ||
| Subsequent Events | ||
| Surface Acquisition | ||